Rollover Study From EXG-US-01
Clinical trial NCT05868499 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05868499
- Sponsor
- Elixirgen Therapeutics, Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2027-01-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.